Melanocytic nevus epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
===Congenital melanocytic nevi (CMN)===  
===Congenital melanocytic nevi (CMN)===  
*The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.<ref name="pmid17377384">{{cite journal |vauthors=Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L |title=Congenital melanocytic nevus: an epidemiologic study in Italy |journal=Dermatology (Basel) |volume=214 |issue=3 |pages=227–30 |date=2007 |pmid=17377384 |doi=10.1159/000099587 |url=}}</ref>
*The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.<ref name="pmid17377384">{{cite journal |vauthors=Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L |title=Congenital melanocytic nevus: an epidemiologic study in Italy |journal=Dermatology (Basel) |volume=214 |issue=3 |pages=227–30 |date=2007 |pmid=17377384 |doi=10.1159/000099587 |url=}}</ref>
===Melanoma===
*22 in 100,000 people is the age-standardized annual incidence of melanoma worldwide and it has risen more than 10-fold in past ten years.<ref name="pmid8053717">{{cite journal |vauthors=Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ |title=Melanoma risk in individuals with clinically atypical nevi |journal=Arch Dermatol |volume=130 |issue=8 |pages=999–1001 |date=August 1994 |pmid=8053717 |doi= |url=}}</ref><ref name="pmid29313949">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2018 |journal=CA Cancer J Clin |volume=68 |issue=1 |pages=7–30 |date=January 2018 |pmid=29313949 |doi=10.3322/caac.21442 |url=}}</ref>


==References==
==References==

Revision as of 14:10, 21 May 2019

Melanocytic nevus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Melanocytic Nevus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Melanocytic nevus epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Melanocytic nevus epidemiology and demographics

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Melanocytic nevus epidemiology and demographics

CDC on Melanocytic nevus epidemiology and demographics

Melanocytic nevus epidemiology and demographics in the news

Blogs on Melanocytic nevus epidemiology and demographics

Directions to Hospitals Treating Melanocytic nevus

Risk calculators and risk factors for Melanocytic nevus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]

Overview

Darker skin shades tend to have fewer moles compared to fair complexion.

Epidemiology and demographics

Acquired melanocytic nevi

  • The number of acquired moles among white children depends on the geographical area and sun exposure and its intensity.[1]
  • According to the American Academy of Dermatology, the majority of moles appear during the first two decades of a person’s life. [2]
  • Darker skin shades tend to have fewer moles.

Congenital melanocytic nevi (CMN)

  • The prevalence of congenital melanocytic nevi (CMN) in newborns is between 0.2 and 6% worldwide.[3]

Melanoma

  • 22 in 100,000 people is the age-standardized annual incidence of melanoma worldwide and it has risen more than 10-fold in past ten years.[4][5]

References

  1. Valiukeviciene S, Miseviciene I, Gollnick H (May 2005). "The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania". Arch Dermatol. 141 (5): 579–86. doi:10.1001/archderm.141.5.579. PMID 15897379.
  2. Gallagher RP, McLean DI (July 1995). "The epidemiology of acquired melanocytic nevi. A brief review". Dermatol Clin. 13 (3): 595–603. PMID 7554507.
  3. Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L (2007). "Congenital melanocytic nevus: an epidemiologic study in Italy". Dermatology (Basel). 214 (3): 227–30. doi:10.1159/000099587. PMID 17377384.
  4. Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ (August 1994). "Melanoma risk in individuals with clinically atypical nevi". Arch Dermatol. 130 (8): 999–1001. PMID 8053717.
  5. Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.